| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
861 |
794 |
$33K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
453 |
434 |
$28K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
852 |
424 |
$13K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
157 |
153 |
$9K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
73 |
71 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
41 |
40 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
167 |
80 |
$2K |
| 92551 |
|
201 |
199 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
59 |
57 |
$738.15 |
| 85018 |
|
301 |
295 |
$706.32 |
| 96127 |
|
89 |
66 |
$412.83 |
| 81003 |
|
168 |
164 |
$376.53 |
| 80061 |
Lipid panel |
29 |
29 |
$370.98 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
14 |
$171.45 |
| 90474 |
|
13 |
13 |
$119.76 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
15 |
14 |
$0.90 |
| 90670 |
|
19 |
19 |
$0.00 |
| 90685 |
|
15 |
15 |
$0.00 |
| 90698 |
|
17 |
17 |
$0.00 |
| 90680 |
|
14 |
14 |
$0.00 |